Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02611180

Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease

Analysis of Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dendritic cells (DCs) serve as sentries for the immune system. DCs recognize foreign compounds (antigens) in the body, which they internalize and process. When DCs uptake foreign antigens, they migrate to secondary lymphoid organs, where the processed antigens are presented to T cells. Various DC subsets with unique cell lineages, surface protein markers, and tissue localization determinants have been identified. For example, Langerhans cells (LCs) and interstitial dendritic cells (intDCs) are DCs found in stratified epithelia, such as the skin. Though both are expressed in the skin, they differ with respect to their origin and surface protein content and can activate distinct types of immune responses. They may also have different specificities for the capture of antigens and presentation to circulating T cells. To date, it is unknown what role, if any, the different DC populations that reside or repopulate in the skin play in the development and progression of skin graft-versus-host disease (GVHD) following bone marrow transplant.

Conditions

Interventions

TypeNameDescription
PROCEDURESkin punch biopsy
PROCEDUREPeripheral blood draw

Timeline

Start date
2015-04-30
Primary completion
2027-04-30
Completion
2027-04-30
First posted
2015-11-20
Last updated
2026-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02611180. Inclusion in this directory is not an endorsement.